Nanjing Pharmaceutical Group Company Limited (SHA:600713)

China · Delayed Price · Currency is CNY

5.52

+0.02 (0.36%)

Feb 27, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Wholesale - Drugs	53.70B	53.59B	50.22B	45.12B	39.82B
Wholesale - Drugs Growth	0.20%	6.71%	11.30%	13.33%	7.16%
Total	53.70B	53.59B	50.22B	45.12B	39.82B
Total Growth	0.20%	6.71%	11.30%	13.33%	7.16%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	53.70B	53.59B	50.22B	45.12B	39.82B
China Growth	0.20%	6.71%	11.30%	13.33%	7.16%
Total	53.70B	53.59B	50.22B	45.12B	39.82B
Total Growth	0.20%	6.71%	11.30%	13.33%	7.16%

Source: S&P Global Market Intelligence.